Author(s): Lord CJ, Ashworth A
Abstract Share this page
Abstract Biomarkers are of crucial importance in optimizing cancer therapies. In this edition of Clinical Cancer Research, Bañuelos and colleagues assess H2AX phosphorylation as a predictive biomarker of response to DNA damaging agents. We discuss these results as well as the impact that double strand break repair biomarkers may have in cancer therapy.
This article was published in Clin Cancer Res
and referenced in Journal of Cancer Science & Therapy